Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert M. Tynebor is active.

Publication


Featured researches published by Robert M. Tynebor.


Bioorganic & Medicinal Chemistry Letters | 2011

Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1.

Robert M. Tynebor; Meng-Hsin Chen; Swaminathan R. Natarajan; Edward A. O’Neill; James E. Thompson; Catherine E. Fitzgerald; Stephen J. O’Keefe; James B. Doherty

This manuscript concludes the Structure Activity Relationship (SAR) on the pyridazinone scaffold and identifies a compound with subnanomolar p38α activity and 24h coverage in the rat arthritis efficacy model.


Bioorganic & Medicinal Chemistry Letters | 2010

Synthesis and biological activity of 2H-quinolizin-2-one based p38alpha MAP kinase inhibitors.

Robert M. Tynebor; Meng-Hsin Chen; Natarajan; Edward A. O'Neill; James E. Thompson; Catherine E. Fitzgerald; Stephen J. O'Keefe; James B. Doherty

The development and synthesis of potent p38alpha MAP kinase inhibitors containing a 2H-quinolizin-2-one platform is described. Evolution of the 2H-quinolizin-2-one series from an early lead to solving off target activity and pharmacokinetic issues is also discussed.


Synthetic Communications | 2013

Novel Method of Synthesizing Various Five Membered Heterocycles from an Aryl Tribromomethyl Group

Robert M. Tynebor; Elizabeth Millings

Abstract Synthesis of five membered heterocycles from an aryl tribromomethyl functional group is discussed. Exposing a tribromomethyl group to subsequent nucleophilic attacks by a 1,2-di-nucleophilic species promotes the cyclization of five membered heterocycles. Such heterocycles as oxadiazoles, thiadiazole, benzimidazole, benzothioazole, and benzoxazole were synthesized in moderate to good yields. Supplemental materials are available for this article. Go to the publishers online edition of Synthetic Communications® to view the free supplemental file. GRAPHICAL ABSTRACT


Bioorganic & Medicinal Chemistry Letters | 2010

Synthesis and biological activity of 2H-quinolizin-2-one based p38α MAP kinase inhibitors

Robert M. Tynebor; Meng-Hsin Chen; Swaminathan R. Natarajan; Edward A. O’Neill; James E. Thompson; Catherine E. Fitzgerald; Stephen J. O’Keefe; James B. Doherty

The development and synthesis of potent p38alpha MAP kinase inhibitors containing a 2H-quinolizin-2-one platform is described. Evolution of the 2H-quinolizin-2-one series from an early lead to solving off target activity and pharmacokinetic issues is also discussed.


Bioorganic & Medicinal Chemistry Letters | 2010

Synthesis and biological activity of 2 H -quinolizin-2-one based p38α MAP kinase inhibitors

Robert M. Tynebor; Meng-Hsin Chen; Swaminathan R. Natarajan; Edward A. O’Neill; James E. Thompson; Catherine E. Fitzgerald; Stephen J. O’Keefe; James B. Doherty

The development and synthesis of potent p38alpha MAP kinase inhibitors containing a 2H-quinolizin-2-one platform is described. Evolution of the 2H-quinolizin-2-one series from an early lead to solving off target activity and pharmacokinetic issues is also discussed.


Archive | 2006

Hiv reverse transcriptase inhibitors

Sandeep A. Saggar; John T. Sisko; Thomas J. Tucker; Robert M. Tynebor; Dai-Shi Su; Neville J. Anthony


Tetrahedron Letters | 2006

Synthesis of the 2H-quinolizin-2-one scaffold via a stepwise acylation—intramolecular annulation strategy

Swaminathan R. Natarajan; Meng-Hsin Chen; Stephen T. Heller; Robert M. Tynebor; Ellen M. Crawford; Cui Minxiang; Han Kaizheng; Jingchao Dong; Bin Hu; Wu Hao; Shu-Hui Chen


Archive | 2006

P38 kinase inhibiting agents

Meng-Hsin Chen; James B. Doherty; Robert M. Tynebor


Archive | 2006

Heterobicyclic compounds useful as p38 kinase inhibiting agents

Meng-Hsin Chen; James B. Doherty; Robert M. Tynebor; Swaminathan R. Natarajan; Zhen Li; Soumya P. Sahoo


Archive | 2013

CAPROLACTAM MGLUR5 RECEPTOR MODULATORS

John T. Sisko; Thomas J. Tucker; Robert M. Tynebor

Researchain Logo
Decentralizing Knowledge